Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
about
Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial.One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function.
P2860
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@en
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@nl
type
label
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@en
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@nl
prefLabel
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@en
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@nl
P2093
P2860
P356
P1476
Antiretroviral therapy in HIV- ...... covery of monocyte activation.
@en
P2093
Jocelin Joseph
Juan G Sierra-Madero
Livio Azzoni
Luis J Montaner
Matthew G Fair
Mohammed S Rassool
Sean C Patro
P2860
P304
P356
10.1189/JLB.5AB0915-406R
P50
P577
2015-11-25T00:00:00Z